Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K

PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants

Gary Kohanbash1,2, Scott Ryall3,4,5, Sam E Gary6

  • 1Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA. gary.kohanbash@pitt.edu.

Journal of Neuro-Oncology
|March 5, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
FGFR1PTPN11Brain tumorGliomaNoonan syndrome

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.7K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.7K

Articles linked to this work by shared authors, journal, and citation graph.

MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression in mice.

Nature communications·2026

Phase 1 clinical trial of S64315, an intravenous MCL1 inhibitor, in patients with myeloid malignancies.

Leukemia & lymphoma·2026

MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities.

Cell reports·2026

Spatially Resolved Microglial State Transitions Govern Strain-Specific Zika Neuropathogenesis.

bioRxiv : the preprint server for biology·2026

Translation of Intraoperative Molecular Imaging for Clinical Use.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

[64Cu]Cu-Labeled αCD11b Diabody as a Novel PET Tracer for the Detection of Immunosuppression in Glioblastoma.

ACS omega·2026

Early experience with cerebrospinal fluid cell-free DNA molecular profiling in a neuro-oncology practice.

Journal of neuro-oncology·2026

[18F]FET uptake in diffuse lower-grade IDH-mutant glioma correlates with glioma-related epilepsy.

Journal of neuro-oncology·2026

A patient-derived organoid platform for predominantly posterior fossa adult ependymoma: histopathologic preservation, culture-associated transcriptomic remodeling, and in vivo tumorigenicity.

Journal of neuro-oncology·2026

A novel minimally invasive diagnostic approach of various brain malignancies based on differential miRNA expression.

Journal of neuro-oncology·2026

Machine learning and computational approaches to model therapeutic response and resistance in diffuse midline glioma.

Journal of neuro-oncology·2026

White matter pathlength maps from diffusion-weighted MRI tractography for radiotherapy target planning in glioblastoma.

Journal of neuro-oncology·2026

Macrophage-Based Nanoplatforms for Tumor-Targeted Drug Delivery and Cancer Immunomodulation: Extracellular Vesicles, Membrane-Coated Nanoparticles, and Live Cells.

International journal of nanomedicine·2026

Engineering Nanoparticles to Navigate Biological Barriers for Deep Tumor Penetration.

Small (Weinheim an der Bergstrasse, Germany)·2026

Trustworthy Governance of Genomic and Health-Related Data: Lessons from Singapore.

Asian bioethics review·2026

Meningococcal meningitis in patients under prolonged eculizumab therapy: Clinical and immunological observations from a case series.

Nefrologia·2026

Modular Bio-Integrated Materials and Devices for Advanced Theranostic Healthcare.

Advanced materials (Deerfield Beach, Fla.)·2026

Multimodal neuroimaging in dementia and neurodegenerative disorders: complementary roles of clinically available nuclear medicine and MRI in the era of disease-modifying therapies.

Japanese journal of radiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us